We served as lead regulatory counsel to a private equity investment firm related to the financing of a complex buyout and restructuring of a company providing physician management and radiation oncology management services and cancer centers.
Private Equity Buyout and Restructuring of Physician Management and Oncology Services Company
You Also May Be Interested In:
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee